Product nameRecombinant Measles virus Priorix, Schwarz strain, nucleocapsid protein
Purity> 95 % SDS-PAGE.
ab74559 is purified by ultracentifugation.
Expression systemSaccharomyces cerevisiae
Protein lengthFull length protein
Our Abpromise guarantee covers the use of ab74559 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. After reconstitution store at -20ºC. Avoid freeze / thaw cycles.
ReconstitutionLyophilised, reconstitute with 120µl deionised water and add glycerol to 50%
RelevancePriorix is a new investigational measles, mumps and rubella (MMR) vaccine containing the Schwarz measles strain, the RA 27/3 rubella strain and a new mumps strain RIT 4385.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab74559 has been referenced in 3 publications.
- Böröcz K et al. Application of a fast and cost-effective 'three-in-one' MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience. Epidemiol Infect 148:e17 (2020). PubMed: 32014073
- Hong J et al. Correlation between the results of two analytical methods for measuring measles virus neutralizing antibodies in source plasma and therapeutic immunoglobulin products. Biologicals 59:20-28 (2019). PubMed: 30992162
- Richardson SI et al. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. PLoS Pathog 15:e1008064 (2019). PubMed: 31841557